Neurodegenerative disorders of gray matter in childhood

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 3351 times

6

Neurodegenerative disorders of gray matter in childhood

A variety of rare neurodegenerative disorders principally affecting gray matter presents in childhood. In most, the precise etiology remains uncertain, but virtually all are presumed to have a metabolic basis. For convenience they are grouped by their most characteristic regional involvement: cerebral cortex, basal ganglia, cerebellum, brain stem, or spinal cord.

CEREBRAL CORTEX

ALPERS–HUTTENLOCHER SYNDROME OR PROGRESSIVE NEURONAL DEGENERATION OF CHILDHOOD (PNDC)

This is a progressive and uniformly fatal disorder of disputed etiology. It primarily involves cerebral cortex and is usually combined with a characteristic hepatopathy.

MACROSCOPIC APPEARANCES

Lesions may be minimal, patchy, or extensive (Fig. 6.1). In affected regions the cortical ribbon is thin, granular, and brown, and even dehiscent in some poorly fixed brains. The calcarine cortex is often picked out in a remarkably selective and characteristic way. Rarely, there is softening of the occipital white matter.

MICROSCOPIC APPEARANCES

Histologic abnormalities are more widespread than expected from the macroscopic appearances. The patchy lesions do not conform to vascular territories or watershed zones and show a graded intensification and extension of the degenerative process through the depth of the cortical gray matter. Mild superficial spongiosis gives way to increasing sponginess, neuronal loss, and gliosis extending down through the cortex. In severe lesions, the whole ribbon is replaced by a narrow remnant of hypertrophic astrocytes devoid of nerve cells (Fig. 6.2). Neutral fat may be deposited in considerable amounts. Lesions may be symmetric or asymmetric, but there is a striking predilection for the striate cortex. Secondary changes are found in the white matter. Other variable findings include hippocampal sclerosis, cerebellar cortical infarcts, spinal cord tract degeneration, and spongiosis and gliosis in the thalamus (Fig. 6.3), amygdala, substantia nigra, and dentate nuclei.

HEPATIC PATHOLOGY

Nearly all patients show characteristic changes in the liver: the hepatocytes undergo severe microvesicular fatty or oncocytic change (Fig. 6.4). There are hepatocyte necrosis, diffuse haphazard bile duct proliferation, and bridging fibrosis, with disorganization and regeneration that amount to cirrhosis at one end of the histologic spectrum (Fig. 6.5), or end-stage collapse and fibrosis at the other.

BASAL GANGLIA

Progressive disorders primarily affecting the basal ganglia include a number of eponymous neurodegenerative diseases whose morphologic changes overlap to some extent with certain well-characterized inborn errors of metabolism.

HOLOTOPISTIC STRIATAL NECROSIS (FAMILIAL STRIATAL DEGENERATION)

This condition causes a clinicopathologic syndrome that resembles Huntington’s disease but lacks the relevant genetic defect.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Two patterns are observed (Fig. 6.6):

Both patterns may occur in familial cases. Neocortical and cerebellar degeneration may also be found.

NEURODEGENERATION WITH BRAIN IRON ACCUMULATION-1 (HALLERVORDEN–SPATZ DISEASE)

This familial primarily motor disorder maps to 20p13, and is caused by a mutation in the pantothenate kinase gene, PANK2.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Yellow–brown discoloration of the globus pallidus and substantia nigra are evident (Fig. 6.7). Neuronal loss, gliosis, and deposition of iron pigment occur bilaterally in the internal segment of the globus pallidus and the pars reticularis of the substantia nigra. There is also a more widespread distribution of swollen axons (spheroids). Neurochemical studies indicate abnormal cysteine metabolism in the pallidum and it is suggested that cysteine chelates iron, which in turn induces tissue damage mediated by free radicals (see also neuroaxonal dystrophy, in Chapter 33).

CEREBELLUM

CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME TYPE 1 (CDG 1)

The carbohydrate-deficient glycoprotein syndromes are a recently delineated group of disorders associated with hypoglycosylation of glycoproteins. The principal condition is carbohydrate-deficient glycoprotein syndrome type I, an autosomal recessive multisystem disease with early, severe nervous system involvement, often fatal in early infancy.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Brain weight may be normal or slightly reduced, but the hindbrain accounts for 5% or less of the total weight because the cerebellum is

globally small with narrow, prominent, and hard folia (Fig. 6.10). The pontine base is flattened.

CDG1 is characterized microscopically by a subtotal loss of Purkinje and granule cells, extensive loss of cerebellar white matter, and gliosis, while the dentate nucleus and superior cerebellar peduncles appear well preserved. The pontine nuclei and inferior olives show marked neuronal depletion, and the middle and inferior cerebellar peduncles and transverse pontine fibers are extremely atrophic.

At necropsy, pleural and pericardial effusions and ascites are common. The liver shows macrovesicular fatty infiltration (Fig. 6.11), abnormal bile duct plates, and portal fibrosis. The kidneys show pronounced cystic dilatation of tubules and collecting ducts.

CEREBELLOCORTICAL DEGENERATION (JERVIS)

Sporadic or familial (usually autosomal recessive) examples of cerebellar cortical degeneration are occasionally encountered in children, and were first reported by Jervis. Severe developmental delay and

microcephaly from late infancy, epilepsy, and ataxia are the main clinical features, with symptomatic or electrophysiologic evidence of visual failure. Death occurred between 9 months and 16 years of age. These cases may have diverse etiology (see Chapter 29 for a discussion of the modern nosology of cerebellar degenerations).

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Microcephaly and marked cerebellar atrophy are seen macroscopically (Fig. 6.12). Histologic features are cerebellar cortical degeneration, severe Purkinje cell loss accompanied by ‘torpedo’ axonal swellings, asteroid dendritic expansions, and variable granule cell involvement. The inferior olivary nuclei are always involved, but the pontine nuclei are spared. Atrophy of the optic nerves, superior colliculi, lateral geniculate nuclei, and visual cortex can also occur.

AUTOSOMAL DOMINANT CEREBELLAR ATAXIA TYPE II (ADCA II)

This form of autosomal dominant ataxia is distinguished by the occurrence of visual failure. Pedigrees can include affected children, with notably a severe infantile presentation.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Microcephaly, cerebellar atrophy, a shallow pons, and flat inferior olives are accompanied by a subtotal loss of Purkinje cells, lesser depletion of granule cells, Bergmann cell gliosis, severe olivary atrophy, and variable depletion of the nuclei pontis (Fig. 6.13).

BRAIN STEM

MACROSCOPIC AND MICROSCOPIC APPEARANCES

In both Brown–Vialetto–van Laere syndrome and Fazio–Londe disease the main histologic findings are degeneration of:

Additionally in Brown–Vialetto–van Laere syndrome there is degeneration of the sensory cochleovestibular nerves and ventral cochlear nuclei.

INFANTILE NEURO-AXONAL DYSTROPHY (INAD)

Dystrophic axons containing spheroids can occur in a variety of situations, for example in normal aging, children affected by mucoviscidosis, metabolic

disorders, experimental toxicology, and certain inherited disorders (see also Chapter 33). The main examples of the latter are:

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Apart from cerebellar atrophy, macroscopic abnormality in INAD is minimal. Axonal spheroids are widely distributed throughout the CNS (Fig. 6.15), but are most easily found in the cerebellum, brain stem, and spinal cord, notably among the long sensory tracts. They are also present in cerebellar and cerebral white matter, basal ganglia, thalamus, and in the cerebral cortex where their small size makes detection difficult with conventional histology.

The axonal spheroids have the appearance of eosinophilic ovoids that sometimes show a cleft. They are irregularly argyrophilic, and immunoreactive with neurofilament antibodies. The nonspecific esterase technique in frozen sections is particularly effective for detecting spheroids in cortical biopsies.

Myelin pallor or degeneration may be widespread in cerebral and cerebellar white matter. Other findings include cerebellar cortical degeneration, neurofibrillary tangles, and Lewy bodies.

Ultrastructurally, the axonal swellings are packed with tubulovesicular membranous material, often surrounding a central cleft.

LEIGH’S DISEASE (SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY)

The pathologic diagnosis of Leigh’s disease is based upon the occurrence of a peculiar type of vasculonecrotic lesion in a particular topographic distribution within the CNS. These lesions are the common end result of a variety of metabolic defects of mitochondrial origin. As these lesions are the common end point of diverse metabolic defects with various genetic causes, the term syndrome may be more appropriate. Leigh-type lesions may be associated with other mitochondrial syndromes such as MELAS.

MACROSCOPIC APPEARANCES

There are characteristic symmetric circumscribed brown patches or gray lesions, which are sometimes cavitated (Fig. 6.16). These lesions are present in the striatum, subthalamic nucleus, substantia nigra, inferior olives, and hindbrain tegmentum, and often run in a linear fashion below the ventricle.

MICROSCOPIC APPEARANCES

In typical cases there are many vasculonecrotic lesions distributed symmetrically through the CNS. These lesions take three histologic forms (Fig. 6.17), which probably reflect varying chronicity, but the different appearances are often contiguous, suggesting repetitive damage to the area. The oldest lesions are fibrous or cavitated gliotic scars, equivalent to old infarcts. The youngest and least frequent lesions are composed of poorly cellular edematous neuropil with activated macrophages and eosinophilic neurons. The most typical lesion is characterized by numerous foamy macrophages and variable astrocytosis, prominent congested and hypertrophic capillaries, and collapse of the neuropil, within which there are often some normal neurons. This recent lesion (probably several weeks old) resembles the lesions of Wernicke’s encephalopathy, but there is never any hemosiderin deposition.

image

image

image

image

image

image

image

image

6.17 Leigh’s disease.
(a) In the youngest lesions subtle histologic changes include tissue edema and neuronal necrosis. (b–d) The more characteristic changes are a variable mixture of tissue necrosis, macrophage infiltration, hypertrophy of astrocytes, and a prominent vascularity. Characteristically, some neurons are intact within the areas of partial necrosis. (e) The oldest lesions are merely glial-lined cavities. Histologic section of the midbrain shown in Fig. 6.16 f. (f) Degeneration of the central white matter of the optic nerves. (g) Lesions may also involve the periventricular white matter, here showing very ancient cavities. (h) Cerebellar degeneration is quite common. In this example, loss of Purkinje cells is accompanied by profuse ‘torpedo’ formation, shown by neurofilament protein immunohistochemistry.

Symmetric lesions, often confined to the same part of a nucleus, are found in many gray areas (Table 6.1). Lesions are nearly always present in the substantia nigra, but in only about 50% of patients in the striatum and inferior olives, notably in those patients dying after the first year.

Table 6.1

Frequency of gray matter lesions in Leigh’s disease

Affected region Approximate frequency (%)
Caudate nucleus 50
Putamen 50
Globus pallidus 25
Substantia nigra 95
Thalamus 33
Periaqueductal gray 60
Mammillary bodies Rare
Subthalamic nucleus 40
Red nucleus 33
Superior colliculus 25
Inferior colliculus 80
Pontine tegmentum 60
Cerebellar nuclei 60
Inferior olivary nucleus 50
Medullary tegmentum 80
Spinal gray matter 75

Other features include spongy vacuolation or severe myelin loss in the optic nerves and tracts, spinal cord, centrum semiovale, and cerebellar white matter, and patchy loss of Purkinje cells associated with ‘torpedo’ formation.

SPINAL CORD

SPINAL MUSCULAR ATROPHY (SMA)

The group of disorders known as spinal muscular atrophy is characterized by degeneration of anterior horn cells in the spinal cord. These disorders form the second most common lethal autosomal recessive disorder after cystic fibrosis. The internationally agreed classification divides them into three categories:

MACROSCOPIC AND MICROSCOPIC APPEARANCES

At necropsy, there is a striking atrophy of anterior spinal nerve roots and motor nerves (Fig. 6.18). There is usually a profound loss of anterior horn cells and gliosis at many levels of the spinal cord. In the early stages there are acute degenerative changes such as chromatolysis and microglial nodules. The degenerative process may also extend to the bulbar cranial nerve nuclei and sometimes to the dorsal root sensory ganglion cells.

Muscle biopsy at first shows atrophy of all fiber types, and then compensatory hypertrophy due to collateral sprouting of residual intact nerve fibers, which produces grouping of large and small fibers. Groups of hypertrophic type I fibers are particularly common in SMA. Secondary myopathic changes, including endomysial fibrosis, may be prominent in chronic forms of SMA.

SMA VARIANTS

There are several similar clinical entities of diverse genetic background that cause anterior horn cell degeneration and these should be differentiated from the typical acute form of SMA. Table 6.2 places them in context alongside SMA and the progressive bulbar palsies of childhood.

REFERENCES

Bertini, E., Gadisseux, J.L., Palmieri, G., et al. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy. Am J Med Genet.. 1989;33:328–335.

Cavanagh, J.B., Harding, B.N. Pathogenic factors underlying the lesions in Leigh’s disease: tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain.. 1994;117:1357–1376.

Chou, S.M., Wang, H.S. Aberrant glycosylation/phosphorylation in chromatolytic motoneurons of Werdnig–Hoffmann disease. J Neurol Sci.. 1997;152:198–209.

Friede, R.L. Developmental neuropathology. Berlin: Springer-Verlag; 1989.

Gallai, V., Hockaday, J.M., Hughes, J.T., et al. Ponto-bulbar palsy with deafness (Brown–Vialetto–Van Laere syndrome). J Neurol Sci.. 1981;50:259–275.

Goutières, F., Aicardi, J., Farkas, E. Anterior horn cell disease associated with pontocerebellar hypoplasia in infants. J Neurol Neurosurg Psychiatry.. 1977;40:370–378.

Hagberg, B.A., Blennow, G., Kristriansson, B., et al. Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. Pediatr Neurol.. 1993;9:255–262.

Harding, B.N. Progressive neuronal degeneration of childhood with liver disease (Alpers–Huttenlocher syndrome) – a personal review. J Child Neurol.. 1990;5:273–287.

Harding, B.N., Alsanjari, N., Smith, S.J., et al. Progressive neuronal degeneration of childhood with liver disease (Alpers’ disease) presenting in young adults. J Neurol Neurosurg Psychiatry.. 1995;58:320–325.

Horslen, S.P., Clayton, P.T., Harding, B.N., et al. Neonatal onset olivopontocerebellar atrophy and disialotransferrin deficiency syndrome. Arch Dis Child.. 1991;66:1027–1032.

Ikemoto, A., Hirano, A., Matsumoto, S., et al. Synaptophysin expression in the anterior horn of Werdnig–Hoffmann disease. J Neurol Sci.. 1996;136:94–100.

Iwahashi, H., Eguchi, Y., Yasuhara, N., et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature.. 1997;390:413–417.

Kamoshita, S., Takei, Y., Miyao, M., et al. Pontocerebellar hypoplasia associated with infantile motor neuron disease (Norman’s disease). Pediatr Pathol.. 1990;10:133–142.

McShane, M.A., Boyd, S., Harding, B., et al. Progressive bulbar paralysis of childhood: a reappraisal of Fazio–Londe disease. Brain.. 1992;115:1889–1900.

Mellins, R.B., Hays, A.P., Gold, A.P., et al. Respiratory distress as the initial manifestation of Werdnig–Hoffmann disease. Pediatrics.. 1974;53:33–40.

Moretto, G., Sparaco, M., Monarco, S., et al. Cytoskeletal changes and ubiquitin expression in dystrophic axons of Seitelberger’s disease. Clin Neuropathol.. 1993;12:34–37.

Morris, A.A., Singh, K.R., Perry, R.H., et al. Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease. J Child Neurol.. 1996;11:417–419.

Murayama, S., Bouldin, T.W., Suzuki, K. Immunocytochemical and ultrastructural studies of Werdnig–Hoffmann disease. Acta Neuropathol.. 1991;81:408–417.

Naviaux, R.K., Nyhan, W.L., Barshop, B.A., et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers’ syndrome. Ann Neurol.. 1999;45:54–58.

Norman, R.M., Kay, J.M. Cerebello-thalamo-spinal degeneration in infancy: an unusual variant of Werdnig–Hoffmann Disease. Arch Dis Child.. 1965;40:302–308.

Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). 2000. http://www.ncbi.nlm.nih.gov/omim/.

Ozmen, M., Caliskan, M., Goebel, H.H., et al. Infantile neuroaxonal dystrophy:diagnosis by skin biopsy. Brain Dev.. 1991;13:256–259.

Ramaekers, V.T., Lake, B.D., Harding, B., et al. Diagnostic difficulties in infantile neuroaxonal dystrophy: a clinicopathological study of eight cases. Neuropediatrics.. 1987;18:170–175.

Rudnik Schoneborn, S., Forkert, R., Hahnen, E., et al. Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropediatrics. 1996;27:8–15.

Schindler, D., Bishop, D.F., Wolfe, D.E., et al. Neuroaxonal dystrophy due to lysosomal alpha-N-acetylgalactosaminidase deficiency. N Engl J Med.. 1989;320:1735–1740.

Schmalbruch, H., Haase, G. Spinal muscular atrophy: present state. Brain Pathol.. 2001;11:231–247.

Schrank, B., Gotz, R., Gunnersen, J.M., et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A.. 1997;94:9920–9925.

Simic, G., Seso-Simic, D., Lucassen, P.J., et al. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig–Hoffmann disease. J Neuropathol Exp Neurol.. 2000;59:398–407.

Steimann, G.S., Rorke, L.B., Brown, M.J. Infantile neuronal degeneration masquerading as Werdnig–Hoffmann disease. Ann Neurol.. 1980;8:317–324.

Stromme, P., Maehlen, J., Strom, E.H., et al. Post mortem findings in two patients with the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand.. 1991;375(suppl):55–62.

Summers, B.A., Swash, M., Schwartz, M.S., et al. Juvenile-onset bulbospinal muscular atrophy with deafness: Vialetta–van Laere syndrome or Madras-type motor neuron disease? J Neurol.. 1987;234:440–442.

Yamanouchi, Y., Yamanouchi, H., Becker, L.E. Synaptic alterations of anterior horn cells in Werdnig–Hoffmann disease. Pediatr Neurol.. 1996;15:32–35.